Tag Archives: UK regulator to assess best dose regimen of Oxford COVID vaccine

LONDON: Britain’s medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator’s chief executive said on Wednesday. “Our regulatory review is all encompassing. We will look at all available data,” June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency …

Read More »